Rhine bio's proposed US subsidiary
-
Last Update: 2010-10-25
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Business club news on October 25 Rhine Biology (002166) announced that in order to improve the company's current sales and customer service mode in foreign markets and further stabilize its business relationship with foreign customers, the company plans to invest US $1 million to establish a wholly-owned subsidiary in the United States, mainly for subsidiary establishment, office and storage site leasing, talent recruitment and publicity From January to September, the company's total operating revenue was 69.761 million yuan, down 26.48% year on year, and the net profit attributable to shareholders of the listed company was - 10.259 million yuan, down 195.70% year on year It is estimated that the annual operating performance of the company is still at a loss, with the loss amount between 13 million yuan and 18 million yuan.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
